Gene expression deconvolution for uncovering molecular signatures in response to therapy in juvenile idiopathic arthritis

BBOP Study Consortium

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Gene expression-based signatures help identify pathways relevant to diseases and treatments, but are challenging to construct when there is a diversity of disease mechanisms and treatments in patients with complex diseases. To overcome this challenge, we present a new application of an in silico gene expression deconvolution method, ISOpure-S1, and apply it to identify a common gene expression signature corresponding to response to treatment in 33 juvenile idiopathic arthritis (JIA) patients. Using pre- and post-treatment gene expression profiles only, we found a gene expression signature that significantly correlated with a reduction in the number of joints with active arthritis, a measure of clinical outcome (Spearman rho = 0.44, p = 0.040, Bonferroni correction). This signature may be associated with a decrease in T-cells, monocytes, neutrophils and platelets. The products of most differentially expressed genes include known biomarkers for JIA such as major histocompatibility complexes and interleukins, as well as novel biomarkers including α-defensins. This method is readily applicable to expression datasets of other complex diseases to uncover shared mechanistic patterns in heterogeneous samples.

Original languageEnglish (US)
Article numbere0156055
JournalPLoS One
Volume11
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Juvenile Arthritis
arthritis
Deconvolution
Gene expression
Transcriptome
Gene Expression
gene expression
therapeutics
Biomarkers
biomarkers
Defensins
Therapeutics
T-cells
Interleukins
major histocompatibility complex
interleukins
Platelets
Major Histocompatibility Complex
Computer Simulation
monocytes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Gene expression deconvolution for uncovering molecular signatures in response to therapy in juvenile idiopathic arthritis. / BBOP Study Consortium.

In: PLoS One, Vol. 11, No. 5, e0156055, 01.05.2016.

Research output: Contribution to journalArticle

@article{33b6229602d94e80a532a772f7f9cfc6,
title = "Gene expression deconvolution for uncovering molecular signatures in response to therapy in juvenile idiopathic arthritis",
abstract = "Gene expression-based signatures help identify pathways relevant to diseases and treatments, but are challenging to construct when there is a diversity of disease mechanisms and treatments in patients with complex diseases. To overcome this challenge, we present a new application of an in silico gene expression deconvolution method, ISOpure-S1, and apply it to identify a common gene expression signature corresponding to response to treatment in 33 juvenile idiopathic arthritis (JIA) patients. Using pre- and post-treatment gene expression profiles only, we found a gene expression signature that significantly correlated with a reduction in the number of joints with active arthritis, a measure of clinical outcome (Spearman rho = 0.44, p = 0.040, Bonferroni correction). This signature may be associated with a decrease in T-cells, monocytes, neutrophils and platelets. The products of most differentially expressed genes include known biomarkers for JIA such as major histocompatibility complexes and interleukins, as well as novel biomarkers including α-defensins. This method is readily applicable to expression datasets of other complex diseases to uncover shared mechanistic patterns in heterogeneous samples.",
author = "{BBOP Study Consortium} and Ang Cui and Gerald Quon and Rosenberg, {Alan M.} and Yeung, {Rae S.M.} and Quaid Morris and Paul Dancey and Adam Huber and Bianca Lang and Suzanne Ramsey and Elizabeth Stringer and Chetaille, {Anne Laure} and Gilles Boire and Sarah Campillo and Ga{\"e}lle Ch{\'e}deville and Rosie Scuccimarri and Ciar{\'a}n Duffy and Duffy, {Karen Watanabe} and Michele Gibbon and Roman Jurencak and Johannes Roth and Susanne Benseler and Bonnie Cameron and Brian Feldman and Ronald Laxer and Rayfel Schneider and Lynn Spiegel and Shirley Tse and Kiem Oen and Elham Rezaei and Loren Matheson and Janet Ellsworth and Cabral, {David A.} and Jaime Guzman and Kristin Houghton and Ross Petty and Tucker, {Lori B.} and Stuart Turvey",
year = "2016",
month = "5",
day = "1",
doi = "10.1371/journal.pone.0156055",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Gene expression deconvolution for uncovering molecular signatures in response to therapy in juvenile idiopathic arthritis

AU - BBOP Study Consortium

AU - Cui, Ang

AU - Quon, Gerald

AU - Rosenberg, Alan M.

AU - Yeung, Rae S.M.

AU - Morris, Quaid

AU - Dancey, Paul

AU - Huber, Adam

AU - Lang, Bianca

AU - Ramsey, Suzanne

AU - Stringer, Elizabeth

AU - Chetaille, Anne Laure

AU - Boire, Gilles

AU - Campillo, Sarah

AU - Chédeville, Gaëlle

AU - Scuccimarri, Rosie

AU - Duffy, Ciarán

AU - Duffy, Karen Watanabe

AU - Gibbon, Michele

AU - Jurencak, Roman

AU - Roth, Johannes

AU - Benseler, Susanne

AU - Cameron, Bonnie

AU - Feldman, Brian

AU - Laxer, Ronald

AU - Schneider, Rayfel

AU - Spiegel, Lynn

AU - Tse, Shirley

AU - Oen, Kiem

AU - Rezaei, Elham

AU - Matheson, Loren

AU - Ellsworth, Janet

AU - Cabral, David A.

AU - Guzman, Jaime

AU - Houghton, Kristin

AU - Petty, Ross

AU - Tucker, Lori B.

AU - Turvey, Stuart

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Gene expression-based signatures help identify pathways relevant to diseases and treatments, but are challenging to construct when there is a diversity of disease mechanisms and treatments in patients with complex diseases. To overcome this challenge, we present a new application of an in silico gene expression deconvolution method, ISOpure-S1, and apply it to identify a common gene expression signature corresponding to response to treatment in 33 juvenile idiopathic arthritis (JIA) patients. Using pre- and post-treatment gene expression profiles only, we found a gene expression signature that significantly correlated with a reduction in the number of joints with active arthritis, a measure of clinical outcome (Spearman rho = 0.44, p = 0.040, Bonferroni correction). This signature may be associated with a decrease in T-cells, monocytes, neutrophils and platelets. The products of most differentially expressed genes include known biomarkers for JIA such as major histocompatibility complexes and interleukins, as well as novel biomarkers including α-defensins. This method is readily applicable to expression datasets of other complex diseases to uncover shared mechanistic patterns in heterogeneous samples.

AB - Gene expression-based signatures help identify pathways relevant to diseases and treatments, but are challenging to construct when there is a diversity of disease mechanisms and treatments in patients with complex diseases. To overcome this challenge, we present a new application of an in silico gene expression deconvolution method, ISOpure-S1, and apply it to identify a common gene expression signature corresponding to response to treatment in 33 juvenile idiopathic arthritis (JIA) patients. Using pre- and post-treatment gene expression profiles only, we found a gene expression signature that significantly correlated with a reduction in the number of joints with active arthritis, a measure of clinical outcome (Spearman rho = 0.44, p = 0.040, Bonferroni correction). This signature may be associated with a decrease in T-cells, monocytes, neutrophils and platelets. The products of most differentially expressed genes include known biomarkers for JIA such as major histocompatibility complexes and interleukins, as well as novel biomarkers including α-defensins. This method is readily applicable to expression datasets of other complex diseases to uncover shared mechanistic patterns in heterogeneous samples.

UR - http://www.scopus.com/inward/record.url?scp=84971636107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971636107&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0156055

DO - 10.1371/journal.pone.0156055

M3 - Article

C2 - 27244050

AN - SCOPUS:84971636107

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0156055

ER -